PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 13,696 Shares of Company Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 13,696 shares of the business’s stock in a transaction dated Thursday, October 22nd. The stock was sold at an average price of $47.55, for a total value of $651,244.80. Following the transaction, the chief executive officer owned 54,257,117 shares of the company’s stock, valued at $2,579,925,913.35. The trade was a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The shares were sold at an average price of $48.60, for a total value of $3,349,366.20.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total transaction of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total transaction of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The stock was sold at an average price of $47.27, for a total transaction of $5,201,354.45.
• On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The stock was sold at an average price of $45.00, for a total transaction of $10,440.00.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16.
• On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total value of $1,550,162.75.
• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total value of $1,033,395.84.

PACS Group Stock Up 2.7%

Shares of NYSE PACS traded up $1.27 during mid-day trading on Monday, reaching $48.91. 1,093,217 shares of the company’s stock were exchanged, compared to its average volume of 844,852. PACS Group, Inc. has a twelve month low of $10.31 and a twelve month high of $49.78. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $7.74 billion, a price-to-earnings ratio of 25.34, a PEG ratio of 1.49 and a beta of -0.08. The business has a fifty day simple moving average of $43.85 and a 200 day simple moving average of $39.65.

PACS Group (NYSE:PACS) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. As a group, equities analysts expect that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. upped their target price on shares of PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Oppenheimer lifted their target price on PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Truist Financial set a $62.00 target price on PACS Group in a research note on Wednesday, September 2nd. UBS Group upped their price target on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Finally, Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $58.80.

Hedge Funds Weigh In On PACS Group

Large investors have recently modified their holdings of the business. Dimensional Fund Advisors LP raised its holdings in PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after acquiring an additional 614,250 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in PACS Group during the second quarter valued at approximately $8,196,000. Principal Financial Group Inc. bought a new position in PACS Group in the first quarter valued at approximately $3,171,000. Arrowstreet Capital Limited Partnership grew its stake in PACS Group by 44.6% in the first quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock valued at $9,274,000 after purchasing an additional 89,067 shares in the last quarter. Finally, Cantor Fitzgerald Investment Advisors L.P. bought a new stake in shares of PACS Group during the 3rd quarter worth approximately $1,920,000.

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.